Infinium PharmachemNSE:INFINIUM +2.15%86 ROA % is 7.19% as of Mar. 2026, which is 25% below its 10-year median of 9.62. GuruFocus rates NSE:INFINIUM with a GF Score™ of 86/100 and a GF Value™ of ₹303.68 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 1,613 Chemicals companies, Infinium Pharmachem ranks better than 75.14% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Infinium Pharmachem's annualizedNet Income for the quarter that ended in Mar. 2026 was ₹131 Mil.
Infinium Pharmachem's average Total Assets over the quarter that ended in Mar. 2026 was ₹1,823 Mil. Therefore, Infinium Pharmachem's annualized ROA % for the quarter that ended in Mar. 2026 was 7.19%.
The historical rank and industry rank for Infinium Pharmachem's ROA % or its related term are showing as below:
NSE:INFINIUM'
s ROA % Range Over the Past 10 Years
Min: 4.16 Med: 9.62 Max: 14.64
Current: 6.47
During the past 7 years, Infinium Pharmachem's highest ROA % was 14.64%. The lowest was 4.16%. And the median was 9.62%.
NSE:INFINIUM's ROA % is ranked better than 75.14% of 1613
companies
in the Chemicals industry
Industry Median: 2.9
vs NSE:INFINIUM: 6.47
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is two times the semi-annual (Mar. 2026) net income data. The Revenue data used here is two times the semi-annual (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Infinium Pharmachem ROA % Related Terms
Infinium Pharmachem ROA % Historical Data
* Premium members only.
The historical data trend for Infinium Pharmachem's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Infinium Pharmachem's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Infinium Pharmachem ROA % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Infinium Pharmachem's ROA % distribution charts can be found below:
* The bar in red indicates where Infinium Pharmachem's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Infinium Pharmachem (NSE:INFINIUM) has a ROA % of 7.19% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Infinium Pharmachem and its competitors. This is 25% below median its historical median of 9.62. Over the past decade, Infinium Pharmachem's ROA % has ranged from 4.16 to 14.64. According to the industry distribution chart, Infinium Pharmachem ranks #401 out of 1613 companies in the Chemicals industry, placing it in the top 24.9%.
Is Infinium Pharmachem's ROA % too high?
Infinium Pharmachem's current ROA % of 7.19% is 25% below median its 10-year median of 9.62. Over the past 10 years, this metric has ranged from a low of 4.16 to a high of 14.64. The Chemicals industry median ROA % is 2.90. Infinium Pharmachem's value of 7.19% is 147.9% above this industry median. Based on the distribution chart, Infinium Pharmachem ranks #401 out of 1613 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Infinium Pharmachem has a GF Score™ of 86/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Infinium Pharmachem's ROA % compare to DOW?
According to the Chemicals industry distribution chart, Infinium Pharmachem ranks #401 out of 1613 companies for ROA %. This places Infinium Pharmachem in the top 25% of its industry — outperforming the majority of peers. The industry median ROA % is 2.90. Infinium Pharmachem's value of 7.19% is 147.9% above this benchmark. Historically, Infinium Pharmachem's own ROA % has ranged from 4.16 to 14.64 over the past decade. While the company's 10-year median is 9.62 vs. the industry median of 2.90, Infinium Pharmachem has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Chemicals company?
The median ROA % among Chemicals companies is 2.90, based on 1,613 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Infinium Pharmachem's current ROA % of 7.19% is 147.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Infinium Pharmachem and its competitors. For the Chemicals industry, the median ROA % is 2.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Infinium Pharmachem's current ROA % is 7.19%, which is 25% below median its own 10-year median of 9.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Infinium Pharmachem stock overvalued right now?
Based on GuruFocus' analysis, Infinium Pharmachem (NSE:INFINIUM) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹303.68, compared to a current price of ₹204.30 — trading 32.7% below its estimated fair value. The current ROA % is 7.19%, which is 25% below median its 10-year median of 9.62 and 147.9% above the Chemicals industry median of 2.90. Infinium Pharmachem's overall GF Score™ is 86/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Infinium Pharmachem (NSE:INFINIUM), the current ROA % is 7.19% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Infinium Pharmachem (NSE:INFINIUM) Overvalued in 2026?
Based on GuruFocus' analysis, Infinium Pharmachem stock appears to be undervalued.
The current stock price of ₹204.30 is trading 32.7% below its estimated GF Value™ of ₹303.68.
GuruFocus considers Infinium Pharmachem to be Significantly Undervalued.
Key valuation signals for NSE:INFINIUM:
ROA %: 7.19% (25% below median its 10-year median of 9.62)
GF Value™: ₹303.68 vs. price of ₹204.30 (32.7% below fair value)
Industry Position: 147.9% above the Chemicals median (#401 of 1613)
No single metric tells the full story. See the NSE:INFINIUM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Infinium Pharmachem Ltd is engaged in the business of manufacturing and supplying Iodine, Iodine Derivatives and Active Pharmaceutical Ingredients (APIs). It provides fully integrated customized services from R & D to Commercial scale manufacturing and packaging for its products to the Pharmaceutical, Agrochemical, Nutraceutical, Speciality Chemicals and various other chemicals Industries.
86GF Score
Get the complete analysis for NSE:INFINIUM
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:INFINIUM has been successfully added to your 
